Browsing tag: contract formulation development

Rubicon Research Limited Q4 FY2026

30th May 2026

Rubicon Research Limited Q4 FY2026 Audited Financial Results.   Rubicon Research Limited, a provider of contract formulation development services to pharmaceutical companies, announced its Q4 FY2026 and FY2026 results. The Company reported a strong financial performance for the quarter and year ended March 31, 2026, with net profit for the quarter rising 112 percent.   Revenue growth for the company was broad-based, with the top 5 products contributing 39% of revenue in Q4 FY2026,

By Vishal Dalwadi
No Comment
Read more

Rubicon Research IPO – Review

7th October 2025

Rubicon Research Limited, a provider of contract formulation development services to pharmaceutical companies, is planning to raise ₹1,378 Crore through an IPO. [Fresh Issue ₹500 Cr + OFS ₹878 Cr] Rubicon research ipo price is ₹461 - ₹485 per share   Rubicon Research: History The Company was originally incorporated as Rubicon Consultants Private Limited, a private limited company under the Companies Act, 1956, on May 06, 1999. The Company was then converted into a public limited

By Vishal Dalwadi
No Comment
Read more

Value Pick Of The Month

FOLLOW FINBLAB ON TWITTER